 Carlyle Group LP is close to acquiring Johnson  Johnsons bloodtesting business for around  billion said people familiar with the matter in a deal that could be announced this week The Washington DCbased privateequity firm is expected to pay between  billion and  billion for the business which makes tests that can reveal a patients blood type and screen for viruses such as HIV and hepatitis C the people said A deal could be announced as soon as Thursday they said The people cautioned the deals
  